Published in Gynecol Endocrinol on September 01, 2010
Uncovering steroidopathy in women with autism: a latent class analysis. Mol Autism (2014) 0.87
The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus. Int J Reprod Med (2014) 0.75
Estrogen, cognition and female ageing. Hum Reprod Update (2006) 1.78
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens (2003) 1.49
Non-genomic actions of sex steroid hormones. Eur J Endocrinol (2003) 1.48
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Menopause (2007) 1.47
Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol (2006) 1.35
Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation (2002) 1.11
Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod (2007) 1.08
Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol (2008) 1.08
Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS One (2008) 1.08
Kallmann syndrome in women: from genes to diagnosis and treatment. Gynecol Endocrinol (2013) 1.02
Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology (2010) 0.98
Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids (2002) 0.98
Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology (2003) 0.97
Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase. Endocr Relat Cancer (2010) 0.97
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology (2004) 0.96
Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. PLoS One (2012) 0.95
Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab (2008) 0.95
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril (2008) 0.95
Endocrinology of menopausal transition and its brain implications. CNS Spectr (2005) 0.93
Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin. Mol Hum Reprod (2008) 0.90
Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. Fertil Steril (2004) 0.90
Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol (2011) 0.88
Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF. J Assist Reprod Genet (2008) 0.88
Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas (2003) 0.87
P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome. Anticancer Res (2006) 0.87
Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study. Gynecol Endocrinol (2010) 0.86
Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol (2009) 0.86
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol (2006) 0.85
Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology (2002) 0.84
Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril (2003) 0.83
Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Invest (2002) 0.83
Might DHEA be considered a beneficial replacement therapy in the elderly? Drugs Aging (2007) 0.83
Pregnancy complications in polycystic ovary syndrome patients. Gynecol Endocrinol (2014) 0.83
Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res (2003) 0.83
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism. Maturitas (2006) 0.82
Sex steroids and breast cancer metastasis. Horm Mol Biol Clin Investig (2010) 0.82
Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Neuroendocrinology (2006) 0.82
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. Gynecol Endocrinol (2014) 0.82
Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol (2002) 0.81
Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas (2005) 0.81
Sexual hormone serum levels and temporomandibular disorders. A preliminary study. Gynecol Endocrinol (2005) 0.81
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecol Endocrinol (2012) 0.81
Effects of oral contraceptives on bone mineral density. Treat Endocrinol (2004) 0.81
Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphin. Fertil Steril (2005) 0.81
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology (2010) 0.80
Androgens and the brain. Maturitas (2007) 0.80
Serum allopregnanolone levels relate to FSFI score during the menstrual cycle. J Sex Marital Ther (2003) 0.80
Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause (2005) 0.80
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects. Int J Eat Disord (2003) 0.80
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol (2007) 0.80
Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause (2008) 0.80
Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats. Menopause (2006) 0.80
Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol Endocrinol (2006) 0.80
Membrane integrity evaluation in rabbit spermatozoa. Eur J Obstet Gynecol Reprod Biol (2002) 0.80
The metabolic syndrome and its components in postmenopausal women. Gynecol Endocrinol (2013) 0.80
Estrogen-like effects of wine extracts on nitric oxide synthesis in human endothelial cells. Maturitas (2011) 0.79
Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome. Maturitas (2012) 0.79
Effects of nomegestrol acetate administration on central and peripheral beta-endorphin and allopregnanolone in ovx rats. J Steroid Biochem Mol Biol (2008) 0.79
Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: effects on central and peripheral allopregnanolone and beta-endorphin. Maturitas (2002) 0.79
Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk. Maturitas (2005) 0.79
Sexually dimorphic effects of testosterone administration on brain allopregnanolone in gonadectomized rats. J Sex Med (2008) 0.79
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome. J Obstet Gynaecol Res (2014) 0.79
One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. Maturitas (2007) 0.79
Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med (2012) 0.79
Paroxetine increases brain-derived neurotrophic factor in postmenopausal women. Menopause (2010) 0.78
Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil Steril (2006) 0.78
Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels. Gynecol Endocrinol (2007) 0.78
Hormone therapy. Menopause (2003) 0.78
Skeletal status and body composition in young women with functional hypothalamic amenorrhea. Gynecol Endocrinol (2011) 0.78
Tibolone activates nitric oxide synthesis in human endothelial cells. J Clin Endocrinol Metab (2004) 0.77
Differential estrogen signaling in endothelial cells upon pulsed or continuous administration. Maturitas (2005) 0.77
Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats. Fertil Steril (2007) 0.77
A randomized control comparison study of culture media (HTF versus P1) for human in vitro fertilization. Eur J Obstet Gynecol Reprod Biol (2004) 0.77
The latest elaboration of the Women's Health Initiative data on hormone replacement therapy and cardiovascular disease in postmenopausal women. Gynecol Endocrinol (2007) 0.77